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The porpoise of the rapport is to study the main steps of the pre-tumour changes of 
tissues under the protecting effect of some pigments from the group of carotenoids. To see the 
tumor development we tried to reproduce them in experimental animals with subcutaneous 
administrated dimethyl-benzanthracen (DMBA). We chose the following carotenoids 
pigments: cantaxanthin and rodoxanthin. For this experiment we used 20 mice, grouped in 
two lots. Group 1: 10 mice subcutaneous inoculated (s.c.) with 0,1 ml DMBA solution; orally 
they received, daily, 0,2 ml cantaxanthin (40 µg cantaxanthin /kgc/day). Group 2: 10 mice 
inoculated s.c. with 0,1 ml DMBA solution and they received orally, daily, 0,2 ml 
rodoxanthin (40 µg rodoxanthin /kgc). The pigments were dissolved in vegetal oil. There had 
been made 2 DMBA inoculations, at 1 month distance, in dorsal subcutaneous region. After 8 
and 12 months from the first DMBA inoculation, some animals were sacrificed. There were 
realized necropsy and histopathology exams. 
After 8 months of the first DMBA inoculation, after the sacrifices we have observed in 
lots, macro- and microscopic, pulmonary and hepatic proliferative lesions. Proliferative 
lesions probably appear because of imunosupresor effect of DMBA.  
After 12 months of the first DMBA inoculation, after the sacrifices we have observed: 
in group 1, histopathologically, hepatic preneoplasic lesions. Animals from group 2 were in a 
poor condition.  In one mouse from group 2 has appeard one tumour at right back leg. In   
lung were numerous metastases. Histopatollogicaly: the primary tumour and the metastasis 
was diagnosticated as fibrosarcoma. 
Depreciation of the general condition on group 2 mices and malignant tumour 
development, in one mouse from the group who received orally rodoxanthin denote fact that 
protector antitumoral effect of rodoxanthin is smaller than effect of cantaxanthin. The subjects 
that have received cantaxanthin have not appeared malign lesions. The fact that fibrosarcoma 
has developed in back right leg, although the mices was inoculated in dorsal region and 
hepatic preneoplasic demonstrate DMBA capacity to induct also tumors in other tissues than 
those from inoculation spot.  
 
